The so-called regular blood vessel flushing, also known as intravenous infusion therapy, is ineffective in lowering blood pressure and has not been proven to be effective in preventing cerebrovascular disease, so we adopt an attitude of neither advocating nor prohibiting “blood vessel flushing. We do not advocate it because in order to prevent cerebrovascular disease, whether it is to prevent the onset of cerebrovascular disease for those who have not yet had it or to prevent recurrence for those who have had it, the key is to control the risk factors: such as controlling blood pressure, controlling blood sugar, treating heart disease, controlling blood lipids, taking anti-platelet aggregation drugs to reduce blood viscosity, quitting smoking, limiting alcohol, moderate aerobic exercise, low salt and low fat balanced diet, psychological balance, weight loss, etc. These are all important measures to prevent cerebrovascular disease. These can be achieved by taking oral antihypertensive, hypoglycemic, lipid-lowering and anti-platelet aggregation medications and by adopting a healthy lifestyle. And we commonly use the “blood vessel” intravenous infusion drugs are mainly two categories; one is the blood circulation drugs to improve the blood circulation, commonly used are ginkgo preparations, blood Cetron, Guggenheim, Dan Hong injection, Guipizide, etc.; the second is the brain protection, improve brain cell metabolism drugs, commonly used are cytarabine, piracetam, oracetam The second is cerebral protection and improvement of brain cell metabolism, commonly used are cytarabine, piracetam, oraracetam, brain protein hydrolysate, etc. These drugs are definitely good for improving the symptoms of dizziness, dizziness and drowsiness caused by insufficient blood supply to the brain, but because the drugs are quickly metabolized, the benefits they bring can never be maintained for three months or six months. So the perception that I can prevent cardiovascular disease by flushing my veins twice a year is not desirable. In addition, there are many potential risks of intravenous infusion: for example, for elderly people with heart problems, infusion may increase the burden on the heart and induce heart failure; the drugs used may also have the risk of allergy and may also produce infusion reactions. Moreover, infusion therapy is more expensive compared to oral medication, which increases the economic burden on families and society, so we do not advocate preventive infusion. What do you mean by not prohibiting it? The elderly are old and it is difficult to change their mindset, so if they strongly request infusion therapy, we should also choose the right medication for them so as not to deny him causing him a psychological burden. In short, whether or not to flush the blood vessels, or to choose an individualized treatment plan, family members had better take the elderly to the neurology department to find a doctor experienced in cerebrovascular disease prevention and treatment, to comprehensively evaluate the risk factors and health status for the elderly, to develop an individualized prevention and treatment plan, not to blindly flush the blood vessels regularly.